{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:06Z","timestamp":1786985466652,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bpobgyn.2025.102602","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:59:35Z","timestamp":1742450375000},"page":"102602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Considerations and approaches for early onset fetal anemia due to red cell alloimmunization"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-8426","authenticated-orcid":false,"given":"Kenneth J.","family":"Moise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102602_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ajog.2004.06.063","article-title":"Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization","volume":"192","author":"Van Kamp","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib2","doi-asserted-by":"crossref","first-page":"S458","DOI":"10.1016\/j.ajog.2023.11.888","article-title":"Maternal rates of alloimmunization at the initiation of pregnancy care: insights from a national cohort","volume":"230","author":"Sugrue","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa2314466","article-title":"Nipocalimab in early onset severe hemolytic disease of the fetus and newborn","volume":"391","author":"Moise","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102602_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000073145","article-title":"Intravenous fetal exchange transfusion before 22 weeks of gestation in early and severe red-cell fetomaternal alloimmunization","volume":"18","author":"Poissonnier","year":"2003","journal-title":"Fetal Diagn Ther"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102602_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/uog.7696","article-title":"Early intrauterine transfusion in severe red blood cell alloimmunization","volume":"36","author":"Yinon","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102602_bib7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/1471-0528.17674","article-title":"Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: a nationwide retrospective cohort study","volume":"131","author":"Van't Oever","year":"2024","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1423-0410.1986.tb00227.x","article-title":"Inhibition of immune phagocytosis by human sera with HLA A, B, C and DR but not with DQ or EM type reactivity","volume":"51","author":"Neppert","year":"1986","journal-title":"Vox Sang"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/01.AOG.0000284623.15170.0d","article-title":"Intraperitoneal transfusion in severe, early-onset rh isoimmunization","volume":"110","author":"Howe","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102602_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39283-3","article-title":"Validation of a non-invasive prenatal test for fetal RhD, C, c, E, K and Fy(a) antigens","volume":"13","author":"Alford","year":"2023","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/AOG.0000000000005692","article-title":"Cell-Free DNA analysis for the determination of fetal red blood cell antigen genotype in individuals with alloimmunized Pregnancies","volume":"144","author":"Rego","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000111599","article-title":"Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion","volume":"23","author":"Fox","year":"2008","journal-title":"Fetal Diagn Ther"},{"issue":"8594","key":"10.1016\/j.bpobgyn.2025.102602_bib13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(88)91896-X","article-title":"Fetal haemoglobin measurement in the assessment of red cell isoimmunisation","volume":"1","author":"Nicolaides","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib14","first-page":"50","article-title":"Thoracic duct function in fetal, newborn, and adult sheep","volume":"29","author":"Johnson","year":"1996","journal-title":"Lymphology"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200001063420102","article-title":"Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization","volume":"342","author":"Mari","year":"2000","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102602_bib16","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.7863\/jum.2007.26.8.1013","article-title":"Middle cerebral artery peak systolic velocity of healthy fetuses in the first half of pregnancy","volume":"26","author":"Tongsong","year":"2007","journal-title":"J Ultrasound Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00404-007-0352-2","article-title":"Doppler waveform indices of the Middle Cerebral Artery of normal fetuses in the first half of pregnancy in the Thai population","volume":"276","author":"Rujiwetpongstorn","year":"2007","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102602_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0897.1998.tb00525.x","article-title":"Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn","volume":"39","author":"Palfi","year":"1998","journal-title":"Am J Reprod Immunol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2025.102602_bib19","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198802253180816","article-title":"High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization","volume":"318","author":"de la Camara","year":"1988","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bpobgyn.2025.102602_bib20","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jaip.2023.04.002","article-title":"Intravenous immunoglobulin: mechanism of action in autoimmune and inflammatory conditions","volume":"11","author":"Bayry","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102602_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/00016349509021196","article-title":"Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus","volume":"74","author":"Gottvall","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102602_bib22","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.ajog.2018.06.007","article-title":"Postponing Early intrauterine transfusion with intravenous immunoglobulin treatment; the PETIT study on severe hemolytic disease of the fetus and newborn","volume":"219","author":"Zwiers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib23","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.18449","article-title":"Intavenous immune globulin in he management of severe early onset of red cell alloimmunization","volume":"200","author":"Vlachodimitropoulou","year":"2023","journal-title":"British J Hematol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2024.03.044","article-title":"Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis","author":"Mustafa","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102602_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tmrv.2013.05.004","article-title":"Adverse effects of human immunoglobulin therapy","volume":"27","author":"Stiehm","year":"2013","journal-title":"Transfus Med Rev"},{"issue":"10","key":"10.1016\/j.bpobgyn.2025.102602_bib26","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1111\/j.1537-2995.2012.03589.x","article-title":"Immune globulins and thrombotic adverse events as recorded in a large administrative database in 2008 through 2010","volume":"52","author":"Daniel","year":"2012","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0002-9378(68)90184-1","article-title":"Intense plasmapheresis in the pregnant Rh-sensitized woman","volume":"101","author":"Powell","year":"1968","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib28","first-page":"173","article-title":"Antenatal therapy for haemolytic disease of the fetus and newborn","volume":"1. 1","author":"Moise","year":"2002"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2141.1980.tb07185.x","article-title":"Intensive plasma exchange in the management of severe Rh disease","volume":"45","author":"Angela","year":"1980","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-Based approach from the writing committee of the American Society for Apheresis: the Ninth Special Issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"issue":"6231","key":"10.1016\/j.bpobgyn.2025.102602_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/bmj.280.6231.1569","article-title":"Adverse effect of plasma exchange on anti-D production in rhesus immunisation owing to removal of inhibitory factors","volume":"280","author":"Barclay","year":"1980","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.bpobgyn.2025.102602_bib33","first-page":"983","article-title":"Intensive immunization of an already sensitized Rh-negative woman; birth of a mildly diseased baby","volume":"34","author":"East","year":"1949","journal-title":"J Lab Clin Med"},{"issue":"8801","key":"10.1016\/j.bpobgyn.2025.102602_bib34","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/0140-6736(92)90661-L","article-title":"Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR)","volume":"339","author":"Dooren","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0609.1999.tb01125.x","article-title":"High incidence of maternal HLA A, B and C antibodies associated with a mild course of haemolytic disease of the newborn. Group for the study of protective maternal HLA antibodies in the clinical course of HDN","volume":"63","author":"Neppert","year":"1999","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102602_bib36","first-page":"157","article-title":"Inhibition of the monocyte chemiluminescent response to anti-D- sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn","volume":"70","author":"Shepard","year":"1996","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.bpobgyn.2025.102602_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-0897.2006.00413.x","article-title":"Transfusion-related risks of intradermal allogeneic lymphocyte immunotherapy: single cases in a large cohort and review of the literature","volume":"56","author":"Kling","year":"2006","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib38","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1067\/mob.2002.126960","article-title":"Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn in a rabbit model","volume":"187","author":"Whitecar","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib39","doi-asserted-by":"crossref","first-page":"16S","DOI":"10.1182\/blood-2020-140558","article-title":"Imunoadsorption, intravenous immunoglobulins and Rituximab (IIR): successful new treatment approach for severe anti-K alloimmunization in pregnancy","volume":"136","author":"Capraru","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bpobgyn.2025.102602_bib40","article-title":"Rituximab before and during pregnancy","volume":"5","author":"Das","year":"2018","journal-title":"Neurol Neroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.bpobgyn.2025.102602_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/uog.24891","article-title":"Targeting neonatal Fc receptor: potential clinical applications in pregnancy","volume":"60","author":"Moise","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2025.102602_bib42","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/cpt.1276","article-title":"M281, an Anti-FcRn Antibody: pharmacodynamics, pharmacokinetics, and safety across the full range of IgG reduction in a first-in-human study","volume":"105","author":"Ling","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bpobgyn.2025.102602_bib43","doi-asserted-by":"crossref","first-page":"e1491","DOI":"10.1016\/j.ajog.2019.02.058","article-title":"M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model","volume":"220","author":"Roy","year":"2019","journal-title":"Am J Obstet Gynecol"},{"issue":"6626","key":"10.1016\/j.bpobgyn.2025.102602_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1136\/bmj.296.6626.885","article-title":"Fetal intracardiac transfusions in patients with severe rhesus isoimmunisation","volume":"296","author":"Westgren","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2025.102602_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000369798","article-title":"Fetal intracardiac transfusions in hydropic fetuses with severe anemia","volume":"38","author":"Mackie","year":"2015","journal-title":"Fetal Diagn Ther"},{"issue":"9","key":"10.1016\/j.bpobgyn.2025.102602_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/pd.1970080906","article-title":"The fetal intrahepatic umbilical vein as an alternative to cord needling for prenatal diagnosis and therapy","volume":"8","author":"Nicolini","year":"1988","journal-title":"Prenat Diagn"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693425000264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T07:23:11Z","timestamp":1748848991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693425000264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":46,"alternative-id":["S1521693425000264"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102602","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Considerations and approaches for early onset fetal anemia due to red cell alloimmunization","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102602"}}